Otsuka Holdings
4578.T
#717
Rank
โ‚น2.438 T
Marketcap
โ‚น4,540
Share price
-1.20%
Change (1 day)
39.42%
Change (1 year)
Otsuka Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company involved in the R&D of drugs and healing methods for respiratory diseases, eye diseases, cardiovascular diseases, neurological and mental diseases as well as Parkinson's, tuberculosis and cancer.

EPS for Otsuka Holdings (4578.T)

EPS in 2023 (TTM): โ‚น200.15

According to Otsuka Holdings 's latest financial reports the company's current EPS (TTM) is โ‚น209.90. In 2022 the company made an earnings per share (EPS) of โ‚น158.27 a decrease over its 2021 EPS that were of โ‚น180.63.

EPS history for Otsuka Holdings from 2010 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น200.1526.46%
2022โ‚น158.27-12.38%
2021โ‚น180.63-18.58%
2020โ‚น221.8518.81%
2019โ‚น186.7355.85%
2018โ‚น119.81-25.05%
2017โ‚น159.8510.15%
2016โ‚น145.137.74%
2015โ‚น134.70-39.2%
2014โ‚น221.54-20.14%
2013โ‚น277.4151.58%
2012โ‚น183.01-6.65%
2011โ‚น196.0529.28%
2010โ‚น151.65